Please login to the form below

Not currently logged in
Email:
Password:

Louise Tamblin returns to Kantar Health as group director

Moves from Strata Research

Kantar Health Louise TamblinLouise Tamblin has re-joined Kantar Health as group director after spending nearly two years as head of research at Strata Research.

Prior to her time at Strata, Tamblin spent eight years at Kantar Health and TNS Healthcare as group director, and before that worked with Intrepid Consultants and in academia.

Kantar Health's UK managing director Jim Needell said: “Louise re-joins us at an exciting time as Kantar Health UK expands its expert teams in market access and clinical trial research, as well as methodology and insight, to deliver excellence throughout the product lifecycle.

“We are delighted to welcome Louise back to our business as we continue to build our senior team.”

8th October 2012

From: PME

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Data Intelligence

Data Intelligence was started in 2006 with the objective of providing world class business intelligence services to pharmaceutical commercial functions....

Latest intelligence

More of the same: The importance of strategic communications planning for biosimilar entry
GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020....
Online Physician Communities
How can pharma realise the power of digital?
Firstly, by making it owned and driven by the most senior leadership team in the business...
Remapping the market: Does Pharma's global model need a shake up?
For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of...